1,923
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Different molecular characteristics and antimicrobial resistance profiles of Clostridium difficile in the Asia-Pacific region

, , , ORCID Icon, , , , , , , , , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1553-1562 | Received 01 Aug 2019, Accepted 14 Oct 2019, Published online: 30 Oct 2019

References

  • Martin JS, Monaghan TM, Wilcox MH. Clostridium difficile infection: epidemiology, diagnosis and understanding transmission. Nat Rev Gastro & Hepatol. 2016 Apr;13(4):206–216. doi: 10.1038/nrgastro.2016.25
  • Barbut F, Gariazzo B, Bonne L, et al. Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000–2004. Infect Control Hosp Epidemiol. 2007 Feb;28(2):131–139. doi: 10.1086/511794
  • Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010 May;31(5):431–455. doi: 10.1086/651706
  • Iwashima Y, Nakamura A, Kato H, et al. A retrospective study of the epidemiology of Clostridium difficile infection at a University Hospital in Japan: genotypic features of the isolates and clinical characteristics of the patients. J Infect Chem. 2010 Oct;16(5):329–333. doi: 10.1007/s10156-010-0066-4
  • Kim H, Jeong SH, Roh KH, et al. Investigation of toxin gene diversity, molecular epidemiology, and antimicrobial resistance of Clostridium difficile isolated from 12 hospitals in South Korea. Korean J Lab Med. 2010 Oct;30(5):491–497. doi: 10.3343/kjlm.2010.30.5.491
  • Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. New Eng J Med. 2015 Feb 26;372(9):825–834. doi: 10.1056/NEJMoa1408913
  • Cairns MD, Preston MD, Hall CL, et al. Comparative genome analysis and global phylogeny of the toxin variant Clostridium difficile PCR ribotype 017 reveals the evolution of two independent sublineages. J Clin Microbial. 2017 Mar;55(3):865–876. doi: 10.1128/JCM.01296-16
  • Knight DR, Elliott B, Chang BJ, et al. Diversity and evolution in the genome of Clostridium difficile. Clin Microbial Rev. 2015 Jul;28(3):721–741. doi: 10.1128/CMR.00127-14
  • Bauer MP, Notermans DW, van Benthem BH, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2011 Jan 1;377(9759):63–73. doi: 10.1016/S0140-6736(10)61266-4
  • Davies KA, Ashwin H, Longshaw CM, et al. Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013. Euro Surv. 2016 Jul 21;21(29). pii:30294.
  • Tickler IA, Obradovich AE, Goering RV, et al. Changes in molecular epidemiology and antimicrobial resistance profiles of Clostridioides (Clostridium) difficile strains in the United States between 2011 and 2017. Anaerobe. 2019 Jun 4. doi: 10.1016/j.anaerobe.2019.06.003
  • Collins DA, Hawkey PM, Riley TV. Epidemiology of Clostridium difficile infection in Asia. Antimicrob Resist Infect Control. 2013 Jul 1;2(1):21. doi: 10.1186/2047-2994-2-21
  • Borren NZ, Ghadermarzi S, Hutfless S, et al. The emergence of Clostridium difficile infection in Asia: a systematic review and meta-analysis of incidence and impact. PloS one. 2017;12(5):e0176797. doi: 10.1371/journal.pone.0176797
  • Kato H, Senoh M, Honda H, et al. Clostridioides (Clostridium) difficile infection burden in Japan: a multicenter prospective study. Anaerobe. 2019 Mar 12;pii: S1075-9964(19):30046-0.
  • Tang C, Cui L, Xu Y, et al. The incidence and drug resistance of Clostridium difficile infection in Mainland China: a systematic review and meta-analysis. Scientific Rep. 2016 Nov 29;6:37865. doi: 10.1038/srep37865
  • Jin D, Luo Y, Huang C, et al. Molecular epidemiology of Clostridium difficile infection in hospitalized patients in Eastern China. J Clin Microbial. 2017 Mar;55(3):801–810. doi: 10.1128/JCM.01898-16
  • Chen YB, Gu SL, Wei ZQ, et al. Molecular epidemiology of Clostridium difficile in a tertiary hospital of China. J Med Microbial. 2014 Apr;63(Pt 4):562–569. doi: 10.1099/jmm.0.068668-0
  • Seo MR, Kim J, Lee Y, et al. Prevalence, genetic relatedness and antibiotic resistance of hospital-acquired Clostridium difficile PCR ribotype 018 strains. Int J Antimicrob Agents. 2018 May;51(5):762–767. doi: 10.1016/j.ijantimicag.2018.01.025
  • Ichihara K, Boyd JC. An appraisal of statistical procedures used in derivation of reference intervals. Clin Chem Lab Med. 2010 Nov;48(11):1537–1551. doi: 10.1515/CCLM.2010.319
  • McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018 Mar 19;66(7):e1–e48. doi: 10.1093/cid/cix1085
  • Persson S, Torpdahl M, Olsen KE. New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection. Clin Microbiol Infect. 2008 Nov;14(11):1057–1064. doi: 10.1111/j.1469-0691.2008.02092.x
  • Griffiths D, Fawley W, Kachrimanidou M, et al. Multilocus sequence typing of Clostridium difficile. J Clin Microbiol. 2010 Mar;48(3):770–778. doi: 10.1128/JCM.01796-09
  • CLSI. Wayne (PA): Clinical and Laboratory Standards Institute.
  • Killgore G, Thompson A, Johnson S, et al. Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J Clin Microbiol. 2008 Feb;46(2):431–437. doi: 10.1128/JCM.01484-07
  • Maiden MC, Jansen van Rensburg MJ, Bray JE, et al. MLST revisited: the gene-by-gene approach to bacterial genomics. Nat Rev Microbiol. 2013 Oct;11(10):728–736. doi: 10.1038/nrmicro3093
  • Collins DA, Riley TV. Clostridium difficile in Asia: opportunities for one health management. Tropical Medicine and Infectious Disease. 2019;4(1):7. doi: 10.3390/tropicalmed4010007
  • Kamboj M, Sheahan A, Sun J, et al. Transmission of Clostridium difficile during hospitalization for allogeneic stem cell transplant. Infect Control Hosp Epidemiol. 2016 Jan;37(1):8–15. doi: 10.1017/ice.2015.237
  • Diniz AN, de Oliveira Junior CA, Vilela EG, et al. Molecular epidemiology of Clostridioides (previously Clostridium) difficile isolates from a university hospital in Minas Gerais, Brazil. Anaerobe. 2019 Apr;56:34–39. doi: 10.1016/j.anaerobe.2019.01.010
  • Huang H, Weintraub A, Fang H, et al. Antimicrobial resistance in Clostridium difficile. Int J Antimicrob Agents. 2009 Dec;34(6):516–522. doi: 10.1016/j.ijantimicag.2009.09.012
  • Dingle KE, Elliott B, Robinson E, et al. Evolutionary history of the Clostridium difficile pathogenicity locus. Gen Biol Evol. 2014 Jan;6(1):36–52. doi: 10.1093/gbe/evt204
  • Cheng AC, Turnidge J, Collignon P, et al. Control of fluoroquinolone resistance through successful regulation, Australia. Emerg Infect Dis. 2012 Sep;18(9):1453–1460. doi: 10.3201/eid1809.111515
  • Avent ML, Hall L, Davis L, et al. Antimicrobial stewardship activities: a survey of Queensland hospitals. Australian Heal Rev. 2014 Nov;38(5):557–563. doi: 10.1071/AH13137
  • Fishman N. Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp Epidemiol. 2012 Apr;33(4):322–327. doi: 10.1086/665010
  • Nagel JL, Kaye KS, LaPlante KL, et al. Antimicrobial stewardship for the infection control practitioner. Infect Dis Clin North America. 2016 Sep;30(3):771–784. doi: 10.1016/j.idc.2016.04.012
  • Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016 May 15;62(10):e51–e77. doi: 10.1093/cid/ciw118
  • Hawkey PM, Marriott C, Liu WE, et al. Molecular epidemiology of Clostridium difficile infection in a major Chinese hospital: an underrecognized problem in Asia? J Clin Microbiol. 2013 Oct;51(10):3308–3313. doi: 10.1128/JCM.00587-13
  • Fang WJ, Jin DZ, Luo Y, et al. Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China. BMC Infect Dis. 2014 Sep 29;14:523. doi: 10.1186/1471-2334-14-523
  • Magill SS, O’Leary E, Janelle SJ, et al. Changes in prevalence of health care-associated infections in U.S. hospitals. N Engl J Med. 2018 Nov 1;379(18):1732–1744. doi: 10.1056/NEJMoa1801550
  • Dubberke ER, Olsen MA. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis. 2012 Aug;55(Suppl 2):S88–S92. doi: 10.1093/cid/cis335
  • Krutova M, Kinross P, Barbut F, et al. How to: surveillance of Clostridium difficile infections. Clin Microbiol Infect. 2018 May;24(5):469–475. doi: 10.1016/j.cmi.2017.12.008